Perspective Therapeutics, Inc. (CATX) Institutional Ownership

Ownership Summary

Perspective Therapeutics, Inc. (NYSE:CATX) appears in 2 institutional 13F filings for the quarter ending December 2025.

• These investors held 0.3% of outstanding shares in December 2025, down from 1.6% in September 2025.
• Their total shares held in CATX decreased -79.5% quarter over quarter, and separately, investors owning Perspective Therapeutics increased 100.0% from a year ago.
• Activity in CATX broke down as 0 buyers, 1 sellers, and 1 unchanged among 2 total holders.
• The aggregate institutional position in Perspective Therapeutics amounted to 250.5K shares as of December 2025, down by 971.47K shares quarter on quarter, and up 100.5K shares year over year.
• As of December 31, 2025, the biggest holder of Perspective Therapeutics is TCG Crossover Management, LLC at 7.92Mn shares, representing 10.65% of shares outstanding.
• The biggest buyers of Perspective Therapeutics for the quarter ending December 2025 included TCG Crossover Management, LLC (7.92Mn), Commodore Capital LP (6.34Mn), VANGUARD CAPITAL MANAGEMENT LLC (4.38Mn), CITADEL ADVISORS LLC (3.3Mn), BALYASNY ASSET MANAGEMENT L.P. (2.99Mn).
• Leading sellers of Perspective Therapeutics shares for the quarter ending December 2025 were Morgan Stanley (1.49Mn), UBS Group AG (405.43K), Nuveen, LLC (363.79K), TWO SIGMA INVESTMENTS, LP (195.17K), Bank Of America Corp /De/ (182.6K).
• Business Quant data shows the 10 biggest positions in Perspective Therapeutics as of December 2025 are held by TCG Crossover Management, LLC (7.92Mn), Commodore Capital LP (6.34Mn), Avidity Partners Management LP (6.05Mn), BlackRock, Inc. (5.35Mn), Opaleye Management Inc. (4.68Mn), VANGUARD CAPITAL MANAGEMENT LLC (4.38Mn), MILLENNIUM MANAGEMENT LLC (4.05Mn), CITADEL ADVISORS LLC (3.57Mn), Affinity Asset Advisors, LLC (3.16Mn), State Street Corp (3.13Mn).